Fragile X Facts: Fragile X syndrome is a rare genetic condition that causes learning disabilities, behavioral symptoms and anxiety. Learn more: https://t.co/QcBA8Mj0D8
If this democracy fails, I think history will look back & say it was due to the commodification of news. Media empires selling consumers the fiction they desired rather than the facts they needed, entertainment rather than info. It’s propaganda for the sake of profit.
Join Fairmount Partners and PACT for a virtual session exploring the P5M Planning Methodology (“P5M”) as a framework for $valuecreation specifically for #emerging growth #technology companies.
Don't miss out - register today at: https://t.co/Jo0SH22by2
#phillytech
If you use it right, Google is the most powerful tool in the world.
But the truth is most people suck at it.
Here are 8 Googling tips that you probably don't know👇
Join Fairmount Partners on 10/12 for "Harnessing the Magic of SaaS Metrics". Currently, public #SaaS companies are trading at record levels and In the 1st session of their Trends in Technology Series, they will be joined by three SaaS experts.
Register: https://t.co/QBGXpBMEMa
We are excited to announce the expansion of our R&D, Clinical and Business Development Teams, and the opening of a research laboratory in JLABS @ TMC to facilitate critical translational research for our drug development programs.
https://t.co/0ivcsAZ8ow
@foodandwine@kittenwithawhip A lovely article on Welsh cakes should not be so frustrating to read. The pages twitches up and down again and again and again (due to ads I assume). Please consider fixing. Thanks, Kat, for your wonderful writing, as always.
Today is #22qawareness day. Today and every day, our team keeps those affected by this #raredisease at the center of everything we do. We’re working to develop a potential new treatment for those with the condition. Learn more about #22q here: https://t.co/s0frqSARpu
Philadelphia-based Mebias Discovery has received a $7.1 million grant from the National Institute on Drug Abuse to support development of the company's new drug candidate designed to prevent and treat opioid use disorder. https://t.co/uKmss6deLy
Congratulations to our CEO Joan Lau for being selected for the @EY_US#EOYPH Entrepreneur of the Year award in Greater Philadelphia!
https://t.co/KjKQ3kNb8K